Once-Weekly Diabetes Treatment Gets FDA OK

WASHINGTON (MedPage Today) — The delay is over for the diabetes Bydureon (exenatide extended-release), with FDA approval making it the first once-weekly treatment for type 2 disease.


Read more

Related posts

Leave a Reply